|
1
|
Peccatori FA, Azim HA Jr, Orecchia R,
Hoekstra HJ, Pavlidis N, Kesic V and Pentheroudakis G; ESMO
Guidelines Working Group, : Cancer, pregnancy and fertility: ESMO
Clinical Practice Guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 24 Suppl 6:vi160–vi170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Embry JR, Kelly MG, Post MD and Spillman
MA: Large cell neuroendocrine carcinoma of the cervix: Prognostic
factors and survival advantage with platinum chemotherapy. Gynecol
Oncol. 120:444–448. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Frumovitz M: Small- and large-cell
neuroendocrine cervical cancer. Oncology (Williston Park).
30:70–77, 78, 93. 2016.PubMed/NCBI
|
|
4
|
Stensheim H, Møller B, van Dijk T and
Fosså SD: Cause-specific survival for women diagnosed with cancer
during pregnancy or lactation: A registry-based cohort study. J
Clin Oncol. 27:45–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pettersson BF, Andersson S, Hellman K and
Hellström AC: Invasive carcinoma of the uterine cervix associated
with pregnancy: 90 years of experience. Cancer. 116:2343–2349.
2010.PubMed/NCBI
|
|
6
|
Córdoba O, Llurba E, Cortés J, Sabadell
MD, Lirola JL, Ferrer Q and Xercavins J: Complete pathological
remission in a patient with hormone-receptor positive and c-erbB-2
expression-negative breast cancer treated with FAC chemotherapy
during pregnancy. Tumori. 96:629–632. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Córdoba O, Bellet M, Vidal X, Cortés J,
Llurba E, Rubio IT and Xercavins J: Pregnancy after treatment of
breast cancer in young women does not adversely affect the
prognosis. Breast. 21:272–275. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Córdoba O, Llurba E, Saura C, Rubio I,
Ferrer Q, Cortés J and Xercavins J: Multidisciplinary approach to
breast cancer diagnosed during pregnancy: Maternal and neonatal
outcomes. Breast. 22:515–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Amant F, Halaska MJ, Fumagalli M,
Steffensen Dahl K, Lok C, Van Calsteren K, Han SN, Mir O, Fruscio
R, Uzan C, et al: Gynecologic cancers in pregnancy: Guidelines of a
second international consensus meeting. Int J Gynecol Cancer.
24:394–403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Balleyguier C, Fournet C, Ben Hassen W,
Zareski E, Morice P, Haie-Meder C, Uzan C, Gouy S, Duvillard P and
Lhommé C: Management of cervical cancer detected during pregnancy:
Role of magnetic resonance imaging. Clin Imaging. 37:70–76. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gardner GJ, Reidy-Lagunes D and Gehrig PA:
Neuroendocrine tumors of the gynecologic tract: A Society of
Gynecologic Oncology (SGO) clinical document. Gynecol Oncol.
122:190–198. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Plante M: Bulky early-stage cervical
cancer (2-4 cm lesions): Upfront radical trachelectomy or
neoadjuvant chemotherapy followed by fertility-preserving surgery:
Which is the best option? Int J Gynecol Cancer. 25:722–728. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Delaloge S, Pautier P, Kerbrat P,
Castaigne D, Haie-Meder C, Duvillard P, Guivarch C, Goupil A, Borel
C and Lhommé C: Neuroendocrine small cell carcinoma of the uterine
cervix: What disease? What treatment? Report of ten cases and a
review of the literature. Clin Oncol (R Coll Radiol). 12:357–362.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zivanovic O, Leitao MM Jr, Park KJ, Zhao
H, Diaz JP, Konner J, Alektiar K, Chi DS, Abu-Rustum NR and
Aghajanian C: Small cell neuroendocrine carcinoma of the cervix:
Analysis of outcome, recurrence pattern and the impact of
platinum-based combination chemotherapy. Gynecol Oncol.
112:590–593. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
National Toxicology Program, . NTP
Monograph: Developmental Effects and Pregnancy Outcomes Associated
With Cancer Chemotherapy Use During Pregnancy. https://ntp.niehs.nih.gov/pubhealth/hat/noms/chemo/index.htmlMay
13–2013
|
|
16
|
Correa A, Cragan JD, Kucik JE, Alverson
CJ, Gilboa SM, Balakrishnan R, Strickland MJ, Duke CW, O'Leary LA,
Riehle-Colarusso T, et al: Reporting birth defects surveillance
data 1968–2003. Birth Defects Res A Clin Mol Teratol. 79:65–186.
2007.PubMed/NCBI
|
|
17
|
Stecklein SR, Jhingran A, Burzawa J,
Ramalingam P, Klopp AH, Eifel PJ and Frumovitz M: Patterns of
recurrence and survival in neuroendocrine cervical cancer. Gynecol
Oncol. 143:552–557. 2016. View Article : Google Scholar : PubMed/NCBI
|
